FDA Advisory Committees and Industry-Funded Patient Advocacy

Claud Mccoid

Cross-posted on Goal Intent and Recognize & Comment.

Sector funding of affected person advocacy businesses lately has obtained interest from media and researchers.  For example, a single 2017 research in the New England Journal of Medication found that around eighty% of affected person advocacy businesses with yearly revenues of at least $seven.5 million noted acquiring industry funding an additional research in JAMA Inner Medication found that approximately 65% of affected person advocacy businesses with a median yearly revenue of about $300,000 noted acquiring industry funding and a article on the Hastings Center’s site (and an before JAMA Inner Medication editorial) noted that a single pharmaceutical organization funded an advocacy group that, in transform, recruited other affected person advocacy teams to converse in favor of the company’s drug when Fda was looking at approving it.  This final story highlights a single space wherever the rubber meets the street with respect to … Read More